Literature DB >> 15184039

Weak prepulses inhibit but do not elicit startle in rats and humans.

Neal R Swerdlow1, Jo Talledo, Jody M Shoemaker, Katie Codon, Jana Goins, Pamela P Auerbach.   

Abstract

BACKGROUND: Inhibition of startle by weak prestimuli is called prepulse inhibition (PPI). It has recently been reported that 10- to 20-dB prepulses trigger eye-blink motor activity and PPI in normal human subjects. Motor activity after prepulses correlated negatively with PPI in four of nine possible conditions. We now report the relationship between prepulse-elicited startle (PPES) and PPI using weak prepulses.
METHODS: We assessed PPI and PPES using 1- to 5-dB prepulses in humans and in rats after treatment with vehicle or apomorphine.
RESULTS: Prepulses inhibited startle in an intensity-dependent fashion but elicited no startle activity in humans or rats. Apomorphine eliminated PPI in rats and produced a well-documented increase in stimulus-independent motor activity but did not stimulate PPES.
CONCLUSIONS: In humans and rats, PPES is not a necessary condition for either the elicitation or the disruption of PPI. Copyright 2004 Society of Biological Psychiatry

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15184039     DOI: 10.1016/j.biopsych.2004.02.030

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Reduced startle gating after D1 blockade: effects of concurrent D2 blockade.

Authors:  Neal R Swerdlow; Jody M Shoemaker; Michele J Bongiovanni; Alaina C Neary; Laura S Tochen; Richard L Saint Marie
Journal:  Pharmacol Biochem Behav       Date:  2005-09-26       Impact factor: 3.533

2.  Prepulse lost and regained: a commentary on "Weak prepulses inhibit but do not elicit startle in rats and humans", Biological Psychiatry 55:98-101.

Authors:  Benjamin K Yee; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2005-01-06       Impact factor: 4.530

3.  Much ado about (almost) nothing: response to 'prepulse lost and regained'.

Authors:  Neal R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2005-01-06       Impact factor: 4.530

4.  Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.

Authors:  Brittney R Lins; Wendie N Marks; Anthony G Phillips; John G Howland
Journal:  Psychopharmacology (Berl)       Date:  2017-02-08       Impact factor: 4.530

Review 5.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

6.  Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.

Authors:  Philipp A Csomor; Benjamin K Yee; Joram Feldon; Anastasia Theodoridou; Erich Studerus; Franz X Vollenweider
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

7.  Wistar-Kyoto rats as an animal model of anxiety vulnerability: support for a hypervigilance hypothesis.

Authors:  J D McAuley; A L Stewart; E S Webber; H C Cromwell; R J Servatius; K C H Pang
Journal:  Behav Brain Res       Date:  2009-06-11       Impact factor: 3.332

8.  Prepulse inhibition of change-related P50m no correlation with P50m gating.

Authors:  Koji Inui; Aki Tsuruhara; Kei Nakagawa; Makoto Nishihara; Minori Kodaira; Eishi Motomura; Ryusuke Kakigi
Journal:  Springerplus       Date:  2013-11-01

9.  Prepulse inhibition of auditory change-related cortical responses.

Authors:  Koji Inui; Aki Tsuruhara; Minori Kodaira; Eishi Motomura; Hisashi Tanii; Makoto Nishihara; Sumru Keceli; Ryusuke Kakigi
Journal:  BMC Neurosci       Date:  2012-10-31       Impact factor: 3.288

10.  Inhibition in the Human Auditory Cortex.

Authors:  Koji Inui; Kei Nakagawa; Makoto Nishihara; Eishi Motomura; Ryusuke Kakigi
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.